RE/MAX $RMAX jumps 22% on $880M sale to Real Brokerage $REAX
Original: Re/Max Stock Surges On News Of Sale To Tech Real Estate Firm View original →
RE/MAX $RMAX jumped about 22% in premarket trading on April 27 after The Real Brokerage $REAX agreed to acquire the company in a transaction valuing RE/MAX at roughly $880M. The move came with an opposite read-through for the buyer: Investor’s Business Daily reported REAX was down nearly 13% ahead of the open as the market priced in financing, integration and dilution risk. For RE/MAX holders, though, the headline was simple: a control premium arrived.
According to the companies’ joint release and the Yahoo Finance-linked IBD report, RE/MAX shareholders can elect to receive 5.15 shares of the new Real REMAX Group or $13.80 in cash, subject to proration that keeps total cash consideration between $60M and $80M. Based on Real’s April 24 close, that implies $13.80 a share for RE/MAX. The companies said the transaction would create a combined platform with more than 180,000 real estate professionals, nearly 8,500 franchisees and operations in over 120 countries and territories.
The strategic pitch is scale plus software. Real brings an AI-enabled brokerage platform, transaction tooling and ancillary services, while RE/MAX contributes a higher-margin franchise network and an iconic consumer brand. On a pro forma basis, management said the combined business would have generated about $2.3B of 2025 revenue and $157M of adjusted EBITDA before synergies. After closing, Real shareholders are expected to own about 59% of the group and RE/MAX holders about 41%, with the stock set to trade under REAX on Nasdaq.
Next comes execution. The companies expect closing in H2 2026, subject to regulatory and shareholder approvals, and Real has lined up a $550M financing commitment to refinance RE/MAX debt and fund the cash piece. Investors will watch whether the promised earnings accretion shows up in the first full year, whether the franchise model and owned-brokerage model can coexist without cultural friction, and whether housing-market softness makes the cost-synergy case harder to deliver than the merger deck suggests.
Not investment advice. Verify all figures with primary sources before acting.
Related Articles
A high-scoring r/StockMarket post surfaced Amazon $AMZN's expanded Anthropic deal: $5B immediately, up to $20B more, and more than $100B of AWS commitments over 10 years.
Organon $OGN rose about 31% before the bell after Sun Pharma $SUNPHARMA agreed to pay $14 a share in cash, valuing the target at $11.75B including debt. Sun said the combination would create a $12.4B-revenue pharma group with a larger women’s-health and biosimilars footprint.
Shell $SHEL agreed to buy ARC Resources $ARX for $16.4B, adding about 370,000 boe/d and roughly 2 billion boe of reserves. The cash-and-stock deal is set to lift Shell's production CAGR through 2030 to 4% and add about $250M of annualized synergies within a year of closing.
Comments (0)
No comments yet. Be the first to comment!